BioSpace News Archive

Business

LEO Pharma and Elektrofi Expand Partnership to Co-Develop New Antibodies with the Aim of Achieving Improvements in Drug Delivery within Dermatology

LEO Pharma A/S and Elektrofi announced an expansion of the two companies’ partnership agreement to further include antibodies from LEO Pharma’s pipeline with the aim of achieving improvements in drug delivery within dermatology.

April 9, 2019
·
2 min read
Alkermes Announces Positive Topline Results From Innovative Study of ARISTADA® and INVEGA SUSTENNA® for the Treatment of Schizophrenia

Large, randomized ALPINE trial showed both long-acting injectable medications effectively controlled schizophrenia symptoms throughout six-month study

April 9, 2019
·
18 min read
Pharm Country

Hälsa Oat Yogurt Expands to Fresh Direct, ShopRite and NYC Airports

Hälsa – the Scandinavian organic drinkable oat yogurt sensation, OatgurtTM – has experienced 120% baseline growth in the past three months.

April 9, 2019
·
2 min read
Business

Checkmate Pharmaceuticals Announces Appointment of Keith T. Flaherty, M.D. to its Board of Directors

Checkmate Pharmaceuticals Inc. announced the addition of Keith T. Flaherty, M.D. to its Board of Directors.

April 9, 2019
·
2 min read
Policy

Ra Pharmaceuticals Announces Completion of End-of-Phase 2 Interactions with FDA and Design of Pivotal Phase 3 gMG Study

Alignment with FDA on a single, pivotal, 12-week, placebo-controlled, Phase 3 clinical trial to initiate in the second half of 2019

April 9, 2019
·
6 min read
Deals

STAAR Surgical to Report First Quarter Results on May 1, 2019

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, announced that it will release financial results for the first quarter ended March 29, 2019 on Wednesday, May 1, 2019 after the market close.

April 9, 2019
·
2 min read
Job Trends

Soliton Completes Cellulite Clinical Trials

Soliton, Inc.,, a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center, announced it has completed the first evaluation timepoint for its proof of concept clinical trial for the treatment of cellulite.

April 9, 2019
·
3 min read
Biotech Beach

OncoSec to Present at H.C. Wainwright Global Life Sciences Conference

OncoSec Medical Incorporated announced that Dan O’Connor, President, Director & Chief Executive Officer, will present a company overview at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 9, 2019, at 2:10 p.m. GMT / 10:10 a.m. EDT in London, United Kingdom.

April 9, 2019
·
2 min read
Policy

Soligenix and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for SGX942

Acceptance of Pediatric Investigation Plan is important milestone on the path to submission of Marketing Authorization Application in Europe

April 9, 2019
·
11 min read
Drug Development

Frequency Therapeutics Announces Positive Phase 1/2 Data for Drug Candidate for Hearing Restoration

Preliminary clinical data suggests improvement on measures of hearing function

April 9, 2019
·
5 min read